Recipharm Acquires Italian CDMO

Source: Globe Newswire

Feb 25, 2016

Recipharm announced that it has entered into an agreement to acquire Italian contract development and manufacturing organization, Mitim.

Mitim, located close to Recipharm’s existing operations in Northern Italy, specializes in the filling of injectable beta lactam products. The $75.5 million deal adds an important technology in the filling of injectable beta lactams to the Recipharm portfolio, helping Recipharm grow sales in the U.S. beta lactams market, as well as capitalize on limited competition for the technology in Europe.

According to Transparency Market Research, the beta-lactams class was the largest segment of the global antibacterial drugs market in 2012, with 57% share.

Read the Globe Newswire press release

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments